SAN DIEGO, June 7, 2016 /PRNewswire/ -- Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting metalloproteins, announced today its participation at the following scientific conferences:
American Society of Microbiology ASM Microbe 2016: Forge Therapeutics scientists will present "Discovery of Non-hydroxamate Inhibitors of LpxC."
Dates: June 16 - 20, 2016
Location: Boston Convention and Exhibition Center, Boston, MA
Gordon Research Conferences: Seth Cohen, Ph.D., co-founder of Forge Therapeutics and Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego is the organizing Vice Chair of 'Metals in Medicine: the interplay of creative chemistry and cellular processes.'
Dates: June 26 – July 1, 2016
Location: Proctor Academy, Andover, NH
American Chemical Society National Meeting & Exposition: Members of the Cohen lab will present research on metalloprotein inhibitor discovery efforts.
Dates: August 21 – 25, 2016
Location: Philadelphia Convention Center, Philadelphia, PA
About Forge Therapeutics, Inc.
Forge Therapeutics, Inc. ("Forge") is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins. Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body. Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins. The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team). Forge Therapeutics, Inc., maintains its headquarters in San Diego, California. To learn more please visit www.ForgeTherapeutics.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/forge-therapeutics-participating-in-scientific-conferences-300280501.html
SOURCE Forge Therapeutics, Inc.